U.S. Department of Health & Human Services

NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Formats Text Remove constraint Formats: Text Copyright Public domain Remove constraint Copyright: Public domain Dates by Range 2000 and later Remove constraint Dates by Range: 2000 and later
Number of results to display per page

Search Results

3. Accelerating adoption of assistive technology to reduce physical strain among family caregivers of the chronically disabled elderly living at home

nlm:nlmuid-101615137-pdf

5. Addressing teen pregnancy risks for youth living in out-of-home care: implementing POWER through choices 2010 : implementation report

nlm:nlmuid-101712270-pdf

6. Administrative procedures for CLIA categorization: guidance for industry and Food and Drug Administration staff

nlm:nlmuid-101719834-pdf

9. The Affordable Care Act and Asian Americans and Pacific Islanders

nlm:nlmuid-101666194-pdf

14. Affordable Care Act: IRS should mitigate limitations of data to be used for the age and gender adjustment for the tax on high-cost health plans : report to Congressional committees

nlm:nlmuid-101727190-pdf

17. The aging services network: accomplishments and challenges in serving a growing elderly population

nlm:nlmuid-101490538-pdf

18. Air ambulance: data collection and transparency needed to enhance DOT oversight : report to the Committee on Transportation and Infrastructure, House of Representatives

nlm:nlmuid-101727033-pdf

23. An analysis of private-sector prices for hospital admissions

nlm:nlmuid-101703988-pdf

26. Anthrax: developing drugs for prophylaxis of inhalational anthrax

nlm:nlmuid-101734212-pdf

27. Antibacterial therapies for patients with an unmet medical need for the treatment of serious bacterial diseases

nlm:nlmuid-101713206-pdf

28. Antibiotic resistance: more information needed to oversee use of medically important drugs in food animals : report to Congressional requesters

nlm:nlmuid-101713360-pdf

29. Antibiotics: FDA has encouraged development, but needs to clarify the role of draft guidance and develop qualified infectious disease product guidance : report to Congressional requesters

nlm:nlmuid-101713330-pdf

36. BCG-unresponsive nonmuscle invasive bladder cancer: developing drugs and biologics for treatment

nlm:nlmuid-101733968-pdf

39. Beyond fair hearings: how five states help Medicaid managed care beneficiaries resolve disputes with health plans

nlm:nlmuid-101616457-pdf

40. Bioanalytical method validation

nlm:nlmuid-101734209-pdf

41. Biodefense: federal efforts to develop biological threat awareness : report to Congressional requesters

nlm:nlmuid-101727231-pdf

48. CDC generally met its inspection goals for the federal select agent program: however, opportunities exist to strengthen oversight

nlm:nlmuid-101737763-pdf

49. CMS did not detect some inappropriate claims for durable medical equipment in nursing facilities

nlm:nlmuid-101738059-pdf

50. CMS validated hospital inpatient quality reporting program data, but should use additional tools to identify gaming

nlm:nlmuid-101737750-pdf

63. Chronic hepatitis C virus infection: developing direct-acting antiviral drugs for treatment

nlm:nlmuid-101719919-pdf

64. Chronic obstructive pulmonary disease: use of the St. George's Respiratory Questionnaire as a PRO assessment tool

nlm:nlmuid-101734084-pdf

65. Clarification of orphan designation of drugs and biologics for pediatric subpopulations of common diseases

nlm:nlmuid-101734398-pdf

66. Classification of products as drugs and devices & additional product classification issues: final guidance : guidance for industry and FDA staff

nlm:nlmuid-101719787-pdf

70. Community-based long-term care: Wisconsin stays ahead : site visit report

nlm:nlmuid-101477700-pdf

71. Compendium of home modification and assistive technology policy and practice across the states. volume I. Final report

nlm:nlmuid-101615139-pdf

72. Competition and choice in the health insurance marketplaces, 2014-2015: impact on premiums

nlm:nlmuid-101665883-pdf

76. Complicated intra-abdominal infections: developing drugs for treatment

nlm:nlmuid-101734269-pdf

77. Complicated urinary tract infections: developing drugs for treatment

nlm:nlmuid-101734286-pdf

80. Considerations for design, development, and analytical validation of next generation sequencing (NGS)--based in vitro diagnostics (IVDs) intended to aid in the diagnosis of suspected germline diseases: guidance for stakeholders and Food and Drug Administration staff

nlm:nlmuid-101734092-pdf

82. Coordination of care for persons with disabilities enrolled in Medicaid managed care: a conceptual framework to guide the development of measures

nlm:nlmuid-101616468-pdf

86. Data inadequacies undermine CMS's oversight of the inconsistency resolution process for the federal marketplace

nlm:nlmuid-101737746-pdf

88. Deciding when to submit a 510(k) for a change to an existing device: guidance for Industry and Food and Drug Administration staff

nlm:nlmuid-101719884-pdf

90. Defense civil support: DOD, HHS, and DHS should use existing coordination mechanisms to improve their pandemic preparedness : report to the Committee on Armed Services, House of Representatives

nlm:nlmuid-101704071-pdf

91. Descriptive study of three disability competent managed care plans for Medicaid enrollees

nlm:nlmuid-101651570-pdf

92. Design considerations and pre-market submission recommendations for interoperable medical devices: guidance for industry and Food and Drug Administration staff

nlm:nlmuid-101713256-pdf

96. Display devices for diagnostic radiology: guidance for industry and Food and Drug Administration staff

nlm:nlmuid-101719840-pdf

99. Drinking water: DOD has acted on some emerging contaminants but should improve internal reporting on regulatory compliance : report to Congressional committees

nlm:nlmuid-101727247-pdf

100. Drinking water: EPA should strengthen ongoing efforts to ensure that consumers are protected from lead contamination : report to congressional requesters

nlm:nlmuid-101638336-bk